Millions of people in low- and middle-income countries die every year from preventable, treatable diseases because they can’t access the lifesaving health products they need. Unitaid was created to address this inequality.
Millions of people in low- and middle-income countries die every year from preventable, treatable diseases because they can’t access the lifesaving health products they need. Unitaid was created to address this inequality.
We save lives by making new health products available and affordable for people in low- and middle-income countries. We identify innovative treatments, tests and tools, help tackle the market barriers that are holding them back, and get them to the people who need them most – fast.
300 m people
Every year, 300 million people use health products we have supported
100 + tools
Since 2006, we have introduced more than 100 groundbreaking interventions
3 x faster
Our approach helps reach global health targets three years faster
US$ 8 bn saved
By 2030, our work is estimated to generate US$8 billion in savings
In a world faced with rising health challenges, governments, industry and global health partners must develop and roll out new health products faster than ever before.
COVID-19 reversed progress toward global health goals, and it’s only a matter of time before we’re faced with the next pandemic. Climate change is pushing diseases like malaria into new communities. Addressing women’s and children’s health is fundamental to the future of global health – but progress has stalled and maternal and child health is underfunded. And tuberculosis, HIV and malaria still kill more than 2.5 million people each year and are becoming increasingly drug-resistant, making them harder to treat. Rising inequalities are blocking access to lifesaving health products for the world’s most vulnerable people, meaning millions continue to suffer and die from preventable, treatable illnesses.
Since we were created in 2006, we have unlocked access to more than 100 groundbreaking treatments, tests and health tools that benefit more than 300 million people in low- and middle-income countries each year.
